Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05800054Recruiting
Randomised, open-label trial in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Body weight at 3 years and Body Mass Index at 3 years. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05800054.